Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Links shared publicly online about this topic.
- 849total visits
Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Allergan - Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
View full resource at agn.client.shareholder.com
Most Recently Shared on September 24, 2010 at 8:37 pm By:
Allergan Gets FDA OK 4 OZURDEX(R) - Trtmnt Option 4 Non-Infectious Uveitis Affecting Posterior Segment of the Eye http://ow.ly/2JA4J
Advertisement
